aadibio.com (WHWK) - Cash Funds per Share

Aadi Bioscience - graphic logo of issuer WHWK

Aadi Bioscience Inc (WHWK) is integrating ESG principles into the development of rare tumor therapies while strictly adhering to testing ethics. The business model is based on the commercialization of niche drugs with minimal competition. The cash per share valuation provided by GURU.Markets demonstrates liquidity, where the 2.90 level records recent values. Future prospects rely on sales volume and the reduction of unprofitable research while maintaining a stable cash balance.

Aadi Bioscience, Inc. (WHWK) Cash Funds per Share: for the period 03/20/2025 - 11/20/2026

Comprehensive metric breakdowns and analytics for aadibio.com (WHWK)

- cash availability and cash flow indicators:
Summary company analysis:Aadi Bioscience Inc
Manufactured product of Aadi Bioscience Inc

Cash per share determines the portion of liquid assets attributable to a single security to assess financial autonomy. At Aadi Bioscience Inc (WHWK), this resource enables the implementation of AI and the robotization of molecular modeling without manual labor. The trend in free cash flow per share reflects the company's ability to fund R&D. An upward trend confirms capital stability, while a decline indicates a risk of dilution or a liquidity shortage.

Key competitors

Cash Funds per Single Share ONC (BeiGene Corp)|Cash per Single Share HALO (Halozyme Therapeutics, Inc.)|Cash per Share Revolution Medicines, Inc. (RVMD)|Cash per Share AAPG (ascentage.com)|CG Oncology Inc (CGON) - Cash on Hand per Share|URGN - Cash Funds per Share|Bicara Bio - Cash Calculated per Single Share|PSNL: Cash per Share|Cash Funds per Single Share ERAS|Cash per Single Share DCTH|Cash on Hand per Share Y-mAbs Therapeutics Inc YMAB|Cash per Share AURA|CADL (Candel Therapeutics, Inc.) - Amount of Cash per Share|Cash Funds per Share Accuray Inc ARAY|Cash Funds Calculated per Share SELLAS Life Sciences Group Inc. (SLS)|actuatetherapeutics.com - Cash per Share|Cash on Hand per Share Citius Oncology|HURA: Cash per Share|Cash Money per Share TARA (Protara)|FATE (fatetherapeutics.com) - Cash per Share|TCRX (TScan Therapeutics) - Cash Calculated per Single Share|Cash Funds per Share Champions Oncology (CSBR)|Cash Funds Calculated per Share XBiotech USA|Cash Funds per Share CEL-SCI CVM|OS Therapies, Inc. (OSTX) - Cash on Hand per Share|RADX - Cash Funds per Share|ARTV - Cash per Share|Adlai Nortye Ltd (ANL) - Cash Funds per Share|Veru Pharma - Amount of Cash per Share|Cash Funds per Share Tempest Therapeutics Corp|Cash Funds per Single Share XLO (Xilio Therapeutics, Inc.)|Cash per Share RENB|MURA (Mural Oncology) - Amount of Cash per Share|Cash per Share KAPA (Kairos Pharma Ltd)|OKUR: Cash Funds per Single Share|GDTC: Cash per Single Share|CRIS - Cash per Share|APLM: Cash per Share|Cash on Hand per Share tharimmune.com (THAR)|ADVB (Advanced Biomed Corp) - Cash per Share|Cash per Share Genprex Inc.|Cash per Share CLDI|Cash per Single Share Sunshine Biopharma, Inc. SBFM|Cash per Share XBIO (Xenetic Biosciences)|Amount of Cash per Share SLRX|PPBT - Cash Funds per Share|AONC (aoncology.com) - Cash Funds per Single Share|BGNE: Cash per Share|Checkpoint Therapeutics Inc (CKPT) - Cash per Share|ELEV (Elevation Oncology Inc.) - Cash per Share|icadmed.com (ICAD) - Cash Funds Calculated per Share|Cash per Share IKNA|NTBL (Notable Labs) - Amount of Cash per Share|Cash per Share VIRX (Viracta Therapeutics)|Cash Funds Calculated per Share MorphoSys AG (MOR)|NAYA Biosciences Corp - Cash per Share|Cash on Hand per Share ascentage.com